# Aurinia Pharmaceuticals
 (stock symbol: AUPH) Logo in transparent PNG format

## Aurinia Pharmaceuticals
 Logo large

### Aurinia Pharmaceuticals
 Logo large Download PNG (11.86 KB)

![Aurinia Pharmaceuticals
 Logo large Download PNG (11.86 KB)](/img/orig/AUPH_BIG-a45bb971.png)

## Aurinia Pharmaceuticals
 Logo icon format

### Aurinia Pharmaceuticals
 Logo icon format Download PNG (4.36 KB)

![Aurinia Pharmaceuticals
 Logo icon format Download PNG (4.36 KB)](/img/orig/AUPH-b2ffd6ad.png)

## About Aurinia Pharmaceuticals


Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

1. Website domain: auriniapharma.com
2. Employees: 300
3. Marketcap: $1.60 Billion USD


## Categories
- [x] ðŸ‡¨ðŸ‡¦ Canada
